Tobi (tobramycin) inhalation solution brand and generic had a market value of approximately $97 million for the most recent 12 months ended April 2019.
The Association for Accessible Medicines' letter to U.S. Trade Representative Robert Lighthizer supports excluding pharmaceuticals and certain pharmaceutical inputs from the expanded list of Chinese exports that will face tariffs.